Evidence for immunological (allergic) mechanisms in a subgroup of patients with phenprocoumon-induced liver disease

European Journal of Clinical Pharmacology

Volumn 65, Issue 12, 2009, Pages 1195-1201

  Klein, Reinhild ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Allergy; Drug induced liver injury; Lymphocyte transformation test; Phenprocoumon

Indexed keywords

PHENPROCOUMON;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG HYPERSENSITIVITY; FEMALE; GERMANY; HUMAN; IMMUNOREACTIVITY; LIVER DISEASE; LYMPHOCYTE TRANSFORMATION TEST; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; DRUG HYPERSENSITIVITY; DRUG-INDUCED LIVER INJURY; FEMALE; GERMANY; HUMANS; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; MALE; MIDDLE AGED; PHENPROCOUMON;

EID: 71349087293     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-009-0705-9     Document Type: Article

References (44)

1. CC Schimanski J Burg M Möhler T Höhler S Kanzler G Otto, et al. 2004 Phenprocoumon-induced liver disease ranges from mild acute hepatitis to (sub-) acute liver failure J Hepatol 41 67 74 10.1016/j.jhep.2004.03.010 1:CAS:528:DC%2BD2cXls1WnsLg%3D 15246210 (Pubitemid 39005155)
2. C Ciorciaro K Hartmann R Stoller M Kuhn 1996 Leberschäden durch Coumarin-Antikoagulantien: Erfahrungen der IKS und der SANZ Schweiz Med Wochenschr 126 2109 2113 1:STN:280:DyaK2s7js1WgsQ%3D%3D 8999497
3. H Mix S Wagner K Böker S Gloger KJ Oldhafer M Behrend, et al. 1999 Subacute liver failure induced by phenprocoumon treatment Digestion 60 579 582 10.1159/000007710 1:CAS:528:DyaK1MXntFGgt70%3D 10545730 (Pubitemid 29495669)
4. S Woolley HR Burger U Zellweger 1995 Phenprocoumon-induced cholestatic hepatitis Dtsch Med Wochenschr 120 1507 1510 10.1055/s-2008-1055506 1:STN:280:DyaK28%2FmvFGhug%3D%3D 7588020
5. A Dorn-Beineke A-W Hassan J Bräutigam R Hildenbrand C-E Dempfle M Schwab 2003 Phenprocoumon-induced hepatitis as an immunologically mediated drug allergic complication of antithrombotic therapy Thromb Haemost 90 1210 1213 14652659
6. C Gondocs L Szalay JM Balo-Banga J Feher 1990 Syncumar okozta toxikus màjkàrosodàs (in Hungarian) Orv Hetil 131 1477 1479 1:STN:280:DyaK3czjt1altQ%3D%3D 2377369
7. AR Schneider D Hartmann JC Arnold MH Bohrer JF Riemann 2001 Phenprocoumon-induced necrotizing hepatitis Dtsch Med Woschenschr 126 457 459 10.1055/s-2001-12889 1:STN:280:DC%2BD3M3nt1KjsQ%3D%3D (Pubitemid 32421578)
8. RA De Man JH Wilson SW Schalm FJ ten Kate E van Leer 1990 Phenprocoumon-induced hepatitis mimicking non-A, non-B hepatitis J Hepatol 11 318 321 10.1016/0168-8278(90)90214-C 1963177
9. H Kreiter U Fink 1967 Ein Fall von Leberschädigung nach Coumarin Medikation Med Klin 62 12 15 1:STN:280:DyaF2s3gs1WgtA%3D%3D 6032217
10. PA Berg EW Becker 1995 The lymphocyte transformation test - a debated method for the evaluation of drug allergic hepatic injury J Hepatol 22 115 118 10.1016/0168-8278(95)80270-3 1:STN:280:DyaK2M3ntV2isQ%3D%3D 7751578
11. WJ Pichler J Tilch 2004 The lymphocyte transformation test in the diagnosis of drug hypersensitivity Allergy 59 809 820 10.1111/j.1398-9995.2004. 00547.x 1:STN:280:DC%2BD2czivFWlsQ%3D%3D 15230812 (Pubitemid 39005820)
12. C Benichou 1990 Criteria of drug-induced liver disorders. Report of an international consensus meeting J Hepatol 11 272 276 10.1016/0168-8278(90)90124- A 1:STN:280:DyaK3M%2Fnt12gtQ%3D%3D 2254635
13. G Danan C Benichou 1999 Causality assessment of adverse reactions to drugs - I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries J Clin Epidemiol 46 1323 1330 10.1016/0895-4356(93)90101-6
14. EM Hennes M Zeniya AJ Czaja A Parés GN Dalekos EL Krawitt, et al. 2008 Simplified criteria for the diagnosis of autoimmune hepatitis Hepatology 48 169 176 10.1002/hep.22322 18537184 (Pubitemid 351975541)
15. NW Brattig GJ Diao PA Berg 1988 The specificity of the lymphocyte transformation test in a patient with hypersensitivity reactions to pyrazolone compounds. A 10-week follow-up study before and after rechallenge Eur J Clin Pharmacol 35 39 45 10.1007/BF00555505 1:STN:280:DyaL1M7itV2jug%3D%3D 3265385 (Pubitemid 18191319)
16. R Klein S Buck K Claen M Rostock R Huber 2008 Enhanced in vitro activation of immunocompetent cells in healthy individuals being subcutaneously 'vaccinated' with placebo (physiological saline) Clin Immunol 126 322 331 10.1016/j.clim.2007.09.007 1:CAS:528:DC%2BD1cXitVWksrc%3D 18345549 (Pubitemid 351221428)
17. AJ Bircher T Harr L Hohenstein DA Tsakiris 2006 Hypersensitivity reactions to anticoagulant drugs: diagnosis and management options Allergy 61 1432 1440 10.1111/j.1398-9995.2006.01227.x 1:CAS:528:DC%2BD28Xhtlarsr7O 17073874 (Pubitemid 44665308)
18. JV Castell M Castell 2006 Allergic hepatitis induced by drugs Curr Opin Allergy Clin Immunol 6 258 265 10.1097/01.all.0000235898.80052.80 1:CAS:528:DC%2BD28XptVKisL0%3D 16825865 (Pubitemid 44510181)
19. A Romano P Demoly 2007 Recent advances in the diagnosis of drug allergy Curr Opin Allergy Clin Immunol 7 299 303 17620820
20. B Nyfeler WJ Pichler 1997 The lymphocyte transformation test for the diagnosis of drug allergy: sensitivity and specificity Clin Exp Allergy 27 175 181 10.1111/j.1365-2222.1997.tb00690.x 1:STN:280:DyaK2s3hsVyntQ%3D%3D 9061217 (Pubitemid 27085418)
21. M Neef Z Kerekes HP Fischer T Sauerbruch U Spengler 2002 Acenocoumarol is not a safe alternative for anticoagulation in phenprocoumon-induced hepatic failure Digestion 67 100 104 10.1159/000070397
22. M Capoferri S Realini B Balestra 2000 Acute necrotizing hepatitis: an unusual side effect of oral anticoagulants Schweiz Rundsch Med Prax 89 929 932 1:STN:280:DC%2BD3czpvVOktw%3D%3D
23. S Ehrenforth JF Schenk I Scharrer 1999 Liver damage induced by coumarin anticoagulants Semin Thromb Hemost 25 79 83 10.1055/s-2007-996428 1:STN:280:DyaK1M3lslWmtQ%3D%3D 10327225
24. Berg PA, Becker EW, Stein GM (1999) Praxisbedeutsame Methoden zum Nachweis allergisch bedingter UAWs. In: Müller-Oerlinghausen B, Lasek R, Düppenbecker H, Munter K-H (eds) Handbuch der unerwünschten Arzneimittelnebenwirkungen. Urban & Fischer, München, Jena, pp 637-649
25. JW Suttie 1985 Vitamin K-dependent carboxylase Annu Rev Biochem 54 459 477 10.1146/annurev.bi.54.070185.002331 1:STN:280:DyaL2M3nsl2qtA%3D%3D 3896125
26. C Vermeer 1984 The vitamin K-dependent carboxylation reaction Mol Cell Biochem 61 17 35 10.1007/BF00239604 1:CAS:528:DyaL2cXhslSnsLs%3D 6369112
27. HF Merck 2005 Diagnosis of drug hypersensitivity: lymphocyte transformation test and cytokines Toxicology 209 217 220 10.1016/j.tox.2004.12. 026 (Pubitemid 40568654)
28. H Moed M von Blomberg DP Bruynzeel, et al. 2005 Improved detection of allergen-specific T-cell responses in allergic contact dermatitis through the addition of 'cytokine cocktails' Exp Dermatol 14 634 640 10.1111/j.0906-6705. 2005.00344.x 1:CAS:528:DC%2BD2MXpsFWktLk%3D 16026586 (Pubitemid 41030931)
29. V von Baehr W Mayer C Liebenthal, et al. 2001 Improving the in vitro antigen specific T cell proliferation assay: the use of interferon-alpha to elicit antigen specific stimulation and decrease bystander proliferation J Immunol Methods 251 63 71 10.1016/S0022-1759(01)00297-6 (Pubitemid 32261057)
30. G Kanny W Pichler M Morisset, et al. 2005 T cell-mediated reactions to iodinated contrast media: evaluation by skin and lymphocyte activation test J Allergy Clin Immunol 115 179 185 10.1016/j.jaci.2004.09.012 1:CAS:528: DC%2BD2MXks1Cg 15637566 (Pubitemid 40075440)
31. MP Holt C Ju 2006 Mechanisms of drug-induced liver injury AAPS J 8 E48 E54 10.1208/aapsj080106 1:CAS:528:DC%2BD28XjsVCisLo%3D 16584133 (Pubitemid 44603865)
32. B Kammerer R Kahlich M Ufer A Schenkel S Laufer CH Gleiter 2005 Stereospecific pharmacokinetic characterisation of phenprocoumon metabolites, and mass-spectrometric identification of two novel metabolites in human plasma and liver microsomes Anal Bioanal Chem 383 909 917 10.1007/s00216-005-0113-7 1:CAS:528:DC%2BD2MXht1SmtLvL 16237546
33. J Kirchheiner M Ufer E-C Walter B Kammerer R Kahlich C Meisel, et al. 2004 Effects of CYP2C9 polymorphisms on the pharmacokinetics of R- and S-phenprocoumon in healthy volunteers Pharmaogenetics 14 19 26 10.1097/00008571-200401000-00002 1:CAS:528:DC%2BD2cXjs1agsL4%3D (Pubitemid 38183958)
34. JX De Vries U Völker 1990 Determination of the plasma protein binding of the coumarin anticoagulants phenprocoumon and its metabolites, warfarin and acenocoumarol, by ultrafiltration and high-performance liquid chromatography J Chromatogr 529 479 485 10.1016/S0378-4347(00)83858-X 2229265 (Pubitemid 20234342)
35. M He KR Korzekwa JP Jones AE Rettie WF Trager 1999 Structural forms of phenprocoumon and warfarin that are metabolized at the active site of CYP2C9 Arch Biochem Biophys 372 16 28 10.1006/abbi.1999.1468 1:CAS:528: DyaK1MXnt1Orsro%3D 10562412
36. S Toon LD Heimark WF Trager RA O'Reilly 1985 Metabolic fate of phenprocoumon in humans J Pharm Sci 74 1037 1040 10.1002/jps.2600741003 1:CAS:528:DyaL2MXmtVGntbk%3D 4078699 (Pubitemid 15231316)
37. M Ufer JO Svensson KW Krausz HV Gelboin A Rane G Tybring 2004 Identification of cytochromes P450 2C9 and 3A4 as the major catalysts of phenprocoumon hydroxylation in vitro Eur J Clin Pharmacol 60 173 182 10.1007/s00228-004-0740-5 1:CAS:528:DC%2BD2cXjvFKnt7Y%3D 15054565 (Pubitemid 38757128)
38. C Enderle W Müller U Grass 2001 Drug interaction: omeprazole and phenprocoumon BMC Gastroenterol 1 2 4 10.1186/1471-230X-1-2 1:STN:280: DC%2BD38nnslCksw%3D%3D 11313000 (Pubitemid 38750976)
39. FJ Penning-van Beest J Koerselman RM Herings 2008 Risk of major bleeding during concomitant use of antibiotic drugs and coumarin anticoagulants J Thromb Haemost 6 284 290 1:CAS:528:DC%2BD1cXjtVKlu7Y%3D 18031295
40. Z Hu X Yang PCL Ho SY Chan PWS Heng E Chan, et al. 2005 Herb-drug interactions Drugs 65 1239 1282 10.2165/00003495-200565090-00005 1:CAS:528:DC%2BD2MXhtVekurfL 15916450 (Pubitemid 41038418)
41. N Kaplowitz 2005 Idiosyncratic drug hepatotoxicity Nat Rev Drug Discov 4 489 499 10.1038/nrd1750 1:CAS:528:DC%2BD2MXks12ktro%3D 15931258 (Pubitemid 40861991)
42. CM zu Schwabedissen V Mevissen F Schmitz S Woodruff G Langebartels T Rau, et al. 2006 Obesity is associated with a slower response to initial phenprocoumon therapy whereas CYP2C9 genotypes are not Eur J Clin Pharmacol 62 713 720 10.1007/s00228-006-0158-3 16847664 (Pubitemid 44289501)
43. NL Brooker Y Kuzimichev J Laas R Pavlis 2007 Evaluation of coumarin derivatives as anti-fungal agents against soil-borne fungal pathogens Commun Agric Appl Biol Sci 72 785 793 1:CAS:528:DC%2BD1cXksFGksrg%3D 18396811
44. M Givel 2003 A comparison of US and Norwegian regulation of coumarin in tobacco products Tob Control 12 401 405 10.1136/tc.12.4.401 1:STN:280: DC%2BD3srotVGjuw%3D%3D 14660776 (Pubitemid 39452042)